By Thomas Swahn, DNP
Psychedelic medicine has been used for thousands of years across various cultures, but our relationship with these substances has been fraught with stigma and fear in recent decades. I believe these medicines have the potential to change our society for the better by increasing openness, love and altruism while reducing anxiety, self-criticism and rumination.
But I didn’t always feel this way.
Like most people, I absorbed many of my ideas from my upbringing and public school education. American culture has spent decades teaching us to see most psychoactive substances as dangerous and without value, through everything from the Controlled Substances Act to the Drug Abuse Resistance Education (DARE) program in schools.
I was conditioned to see them that way right along with everyone else.
It wasn’t until graduate school, when I began seeing research on psilocybin and ketamine, that I started asking deeper questions about these substances and the way we viewed them.
I first became intrigued by ketamine therapy because research showed it could rapidly reduce suicidal ideation in some patients. That caught my attention because suicide has shaped much of my own life.
My father took his life when I was eight years old, leaving behind a devastated spouse and three kids to learn to cope on their own. The next few years brought several suicide attempts from other relatives, spreading further pain through our family.
I spent much of my childhood aware that sometimes people find their lives so painful that they choose to end them.
I wanted so much to be able to change that.
I began reading more about ketamine and choosing it as the subject of my research papers. As I discussed the emerging evidence, I discovered that not everyone was as enthused as I was.
“It makes you hallucinate? I’m not that kind of person. I wouldn’t ever do that.”
It was a surprisingly common sentiment.
The practice of medicine relies on evidence to guide it; how else would we know we’re actually doing what works? Yet I was hearing people dismiss a potentially beneficial treatment not necessarily because of its safety or efficacy, but because the experience itself made them uncomfortable.
That fascinated me.
Why should someone who could potentially benefit from a treatment be afraid of it simply because it alters perception? Why should having that experience make you a certain “kind of person”?
It became clear to me how deeply we had been conditioned to view altered states themselves as immoral, regardless of the potential therapeutic benefit.
After completing my degree, I began providing ketamine therapy and saw firsthand how powerful a treatment it could be. I also had the opportunity to go through several treatments myself, which gave me a much deeper understanding of the medicine’s potential—and its risks.
The experience lifted me out and beyond myself, into the scaffolding of my thoughts and emotions. At times it stripped away negativity and pain and allowed me to look at my life from a different perspective. At others, it plunged me into suppressed emotions and forced me to work through newly exposed material.
It helped me recognize how much of my suffering stemmed from my own assessments and expectations of my life experiences—and that it didn’t always have to be that way.
I began to see my conscious mind and the thoughts it presented to me as separate. I could hold those thoughts without becoming them, using them to my benefit without collapsing under their weight.
It was like wearing armor as I waded into the emotional fray.
But the experience itself is only part of the process.
We call what comes afterward “integration.” Perhaps the most important part of the treatment is contemplating what you experienced, how you felt about it and why those experiences brought those feelings to the surface.
Meditation and mindfulness became my chosen methods for integrating those new understandings into the fabric of my life. I believe the importance of contemplative practices afterward cannot be overstated. This is where we examine our concepts of ourselves and our world, and where we can begin working toward becoming who we want to be.
After years of working with ketamine and reflecting on my own experiences, I have developed a much greater appreciation for the ways psychoactive substances can affect a person’s life—for better or worse.
The important thing is having a healthy relationship with a substance and respecting its risks and costs alongside its potential benefits.
Ketamine is not without risk. Addiction and misuse can occur. At the same time, ketamine is being studied as a potential treatment for substance-use disorders involving alcohol, opioids, nicotine and cocaine. That apparent contradiction is another reason I believe these medicines deserve a more mature and nuanced conversation.
Our society could benefit from striving for more knowledge and less fear.
For those who come from a background like mine, where we considered nearly all drug experiences to be a certain kind of evil, I understand where you’re coming from. But I encourage people to really ask what the risks and benefits might be rather than simply deciding, “I’m not that kind of person.”
Perhaps it’s time for a more open perspective.
Ketamine gave me a unique opportunity to examine my life in a new way—one that helped me take it less seriously and live it more sincerely.
I want people who feel lost to know that it is possible to find their way back to a place where they don’t HAVE to live their life.
They GET to.
And it is beautiful.

About the Author
Thomas Swahn, DNP, APRN, NP-C, is the founder and owner of Swahn Balanced Health in Roy, Utah, where he provides ketamine therapy and medical cannabis evaluations. His work focuses on reducing stigma around psychedelic medicine and helping patients explore evidence-based approaches to mental health and wellness.


